| Peter N Golden, PHARMD | |
|
167 North Main St, Tuba City, AZ 86045 | |
| (928) 283-2754 | |
| Not Available |
| Full Name | Peter N Golden |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 167 North Main St, Tuba City, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073825279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26022541A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter N Golden, PHARMD 809 W Riordan Rd, Ste 100-218, Flagstaff, AZ 86001-0801 Ph: (812) 360-7010 | Peter N Golden, PHARMD 167 North Main St, Tuba City, AZ 86045 Ph: (928) 283-2754 |
News Archive
New research suggests a tailored approach to physical therapy after a neurological injury such as a stroke, traumatic brain injury or spinal cord injury could help restore a wider variety of functions.
Patients with muscle and joint pain are often at least as well served by seeing a physiotherapist as by consulting a doctor when they seek help at a primary health care centre. Over time, the health benefits of first going to a physiotherapist appear slightly superior, new research shows.
NeuroDerm, Ltd. was informed today that it was awarded a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research. These funds will support the next clinical study with ND0611, a new dermal patch for the treatment of Parkinson's disease, as part of the Foundation's prestigious Clinical Intervention Awards 2010 program. This study will evaluate the safety, tolerability, levodopa pharmacokinetics, and possible clinical benefits of ND0611 in advanced Parkinson's disease patients.
Older adults who continue or begin to do any amount of exercise appear to live longer and have a lower risk of disability, according to a report in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.
› Verified 6 days ago
Mursal A Mursal, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Tuba City, AZ 86045 Phone: 928-283-1432 | |
Rachel M Bartlett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main Street, Tuba City, AZ 86045 Phone: 928-283-2754 | |
Dr. David Frank Foss, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 North Main Street, Tuba City Regional Health Care Corporation, Tuba City, AZ 86045 Phone: 928-283-2755 Fax: 928-283-2758 | |
Sarah Sohn, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St., Tuba City, AZ 86045 Phone: 866-976-5941 | |
Daniel Robert Gilberg, PHARMD, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 North Main Street, Tuba City, AZ 86045 Phone: 928-283-2501 Fax: 928-283-2677 | |
Jessica T Lyerly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 N Main St, Tuba City, AZ 86045 Phone: 928-283-1342 Fax: 928-283-2758 | |
Courtney Wong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Tuba City, AZ 86045 Phone: 866-976-5941 |